Recombinant Lactococcus lactis co-expressing OmpH of an M cell-targeting ligand and IBDV-VP2 protein provide immunological protection in chickens

Vaccine

Volumn 36, Issue 5, 2018, Pages 729-735

  Liu, Linlin ^a   Zhang, Wang ^a,b   Song, Yuxin ^a,b   Wang, Wenqian ^a   Zhang, Yuan ^a,b   Wang, Tingting ^a   Li, Kai ^a   Pan, Qing ^a   Qi, Xiaole ^a   Gao, Yulong ^a   Gao, Li ^a   Liu, Changjun ^a   Zhang, Yanping ^a   Wang, Yongqiang ^a   He, Gaoming ^b   Wang, Xiaomei ^a   Cui, Hongyu ^a  

^a INSTITUTE OF PLANT PROTECTION   (China)

^b SHIHEZI UNIVERSITY   (China)

Author keywords

IBDV; OmpH; Recombinant lactic acid bacteria; VP2

Indexed keywords

ANTIVIRUS AGENT; IMMUNOGLOBULIN A; NEUTRALIZING ANTIBODY; PROTEIN VP2; UNCLASSIFIED DRUG; VP2 OMPH PROTEIN; OMPH PROTEIN, BACTERIA; OUTER MEMBRANE PROTEIN; SECRETORY IMMUNOGLOBULIN; VIRAL PROTEIN; VIRUS ANTIBODY; VIRUS VACCINE; VP2 PROTEIN, INFECTIOUS BURSAL DISEASE VIRUS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; BACTERIAL STRAIN; CHICKEN; COMMENSAL; CONTROLLED STUDY; DRUG STABILITY; GENETIC ENGINEERING; HISTOPATHOLOGY; HUMORAL IMMUNITY; IMMUNOPROPHYLAXIS; IMMUNOREACTIVITY; IN VIVO STUDY; INFECTIOUS BURSAL DISEASE VIRUS; LACTOCOCCUS LACTIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS VIRULENCE; WESTERN BLOTTING; ANIMAL; BIRD DISEASE; BIRNAVIRUS INFECTION; GENE EXPRESSION; GENETICS; IMMUNIZATION; IMMUNOLOGY; PATHOLOGY; VETERINARY MEDICINE;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; BACTERIAL OUTER MEMBRANE PROTEINS; BIRNAVIRIDAE INFECTIONS; CHICKENS; GENE EXPRESSION; IMMUNIZATION; IMMUNOGLOBULIN A, SECRETORY; INFECTIOUS BURSAL DISEASE VIRUS; LACTOCOCCUS LACTIS; POULTRY DISEASES; VIRAL STRUCTURAL PROTEINS; VIRAL VACCINES;

EID: 85039153798     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2017.12.027     Document Type: Article

References (34)

1. Wells, J.M., Mercenier, A., Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria. Nat Rev Microbiol 6:5 (2008), 349–362.
2. Bahey-El-Din, M., Gahan, C.G., Griffin, B.T., Lactococcus lactis as a cell factory for delivery of therapeutic proteins. Curr Gene Ther 10:1 (2010), 34–45.
3. Bermúdez-Humarán, L.G., Lactococcus lactis as a live vector for mucosal delivery of therapeutic proteins. Hum Vaccin 5:4 (2009), 264–267.
4. Azizpour, M., Hosseini, S.D., Jafari, P., Akbary, N., Lactococcus lactis: a new strategy for vaccination. Avicenna J Med Biotechnol 9:4 (2017), 163–168.
5. Berg, T.P., Gonze, M., Meulemans, G., Acute infectious bursal disease in poultry: Isolation and characterisation of a highly virulent strain. Avian Pathol 20:1 (1991), 133–143.
6. Mahgoub, H.A., Bailey, M., Kaiser, P., An overview of infectious bursal disease. Arch Virol 157:11 (2012), 2047–2057.
7. Rosenberger, J.K., Klopp, S., Eckroade, R.J., Krauss, W.C., The roles of the infectious bursal agent and several avian adenoviruses in the hemorrhagic-aplastic-anemia syndrome and gangrenous dermatitis. Avian Dis 19:4 (1975), 717–729.
8. Chen, H.Y., Zhou, Q., Zhang, M.F., Giambrone, J.J., Sequence analysis of the VP2 hypervariable region of nine infectious bursal disease virus isolates from mainland China. Avian Dis 42:4 (1998), 762–769.
9. Dieye, Y., Hoekman, A.J., Clier, F., Juillard, V., Boot, H.J., Piard, J.C., Ability of Lactococcus lactis to export viral capsid antigens: a crucial step for development of live vaccines. Appl Environ Microbiol 69:12 (2003), 7281–7288.
10. Hase, K., Kawano, K., Nochi, T., Pontes, G.S., Fukuda, S., Ebisawa, M., et al. Uptake through glycoprotein 2 of FimH(+) bacteria by M cells initiates mucosal immune response. Nature 462:7270 (2009), 226–230.
11. Tyrer, P., Foxwell, A.R., Cripps, A.W., Apicella, M.A., Kyd, J.M., Microbial pattern recognition receptors mediate M-cell uptake of a gram-negative bacterium. Infect Immun 74:1 (2006), 625–631.
12. Keely, S., Glover, L.E., Weissmueller, T., MacManus, C.F., Fillon, S., Fennimore, B., et al. Hypoxia-inducible factor-dependent regulation of platelet-activating factor receptor as a route for gram-positive bacterial translocation across epithelia. Mol Biol Cell 21:4 (2010), 538–546.
13. Kim, S.H., Jung, D.I., Yang, I.Y., Kim, J., Lee, K.Y., Nochi, T., et al. M cells expressing the complement C5a receptor are efficient targets for mucosal vaccine delivery. Eur J Immunol 41:11 (2011), 3219–3229.
14. Schmudde, I., Strover, H.A., Vollbrandt, T., Konig, P., Karsten, C.M., Laumonnier, Y., et al. C5a receptor signalling in dendritic cells controls the development of maladaptive Th2 and Th17 immunity in experimental allergic asthma. Mucosal Immunol 6:4 (2013), 807–825.
15. Kim, S.H., Yang, I.Y., Jang, S.H., Kim, J., Truong, T.T., Van Pham, T., et al. C5a receptor-targeting ligand-mediated delivery of dengue virus antigen to M cells evokes antigen-specific systemic and mucosal immune responses in oral immunization. Microbes Infect 15:13 (2013), 895–902.
16. Hopken, U.E., Lu, B., Gerard, N.P., Gerard, C., The C5a chemoattractant receptor mediates mucosal defence to infection. Nature 383:6595 (1996), 86–89.
17. Platteeuw, C., van Alen-Boerrigter, I., van Schalkwijk, S., de Vos, W.M., Food-grade cloning and expression system for Lactococcus lactis. Appl Environ Microbiol 62:3 (1996), 1008–1013.
18. Lemieux, R., Bazin, R., Novel approaches to the preparation and use of monoclonal antibodies. Transfus Med Rev 7:1 (1993), 25–36.
19. Prandini, F., Simon, B., Jung, A., Pöppel, M., Lemiere, S., Rautenschlein, S., Comparison of infectious bursal disease live vaccines and a HVT-IBD vector vaccine and their effects on the immune system of commercial layer pullets. Avian Pathol 45:1 (2016), 114–125.
20. Müller, H., Mundt, E., Eterradossi, N., Islam, M.R., Current status of vaccines against infectious bursal disease. Avian Pathol 41:2 (2012), 133–139.
21. Xu, X.G., Tong, D.W., Wang, Z.S., Zhang, Q., Li, Z.C., Zhang, K., et al. Baculovirus virions displaying infectious bursal disease virus VP2 protein protect chickens against infectious bursal disease virus infection. Avian Dis 55:2 (2011), 223–229.
22. Pradhan, S.N., Prince, P.R., Madhumathi, J., Roy, P., Narayanan, R.B., Antony, U., Protective immune responses of recombinant VP2 subunit antigen of infectious bursal disease virus in chickens. Vet Immunol Immunopathol 148:3–4 (2012), 293–301.
23. Taghavian, O., Spiegel, H., Hauck, R., Hafez, H.M., Fischer, R., Schillberg, S., Protective oral vaccination against infectious bursal disease virus using the major viral antigenic protein VP2 produced in Pichia pastoris. PLoS One, 8(12), 2013, e83210.
24. Becht, H., Müller, H., Müller, H.K., Comparative studies on structural and antigenic properties of two serotypes of infectious bursal disease virus. J Gen Virol 69:Pt 3 (1988), 631–640.
25. Fahey, K.J., Erny, K., Crooks, J., A conformational immunogen on VP-2 of infectious bursal disease virus that induces virus-neutralizing antibodies that passively protect chickens. J Gen Virol 70:Pt 6 (1989), 1473–1481.
26. Rong, J., Jiang, T., Cheng, T., Shen, M., Du, Y., Li, S., et al. Large-scale manufacture and use of recombinant VP2 vaccine against infectious bursal disease in chickens. Vaccine 25:46 (2007), 7900–7908.
27. Omar, A.R., Kim, C.L., Bejo, M.H., Ideris, A., Efficacy of VP2 protein expressed in E. coli for protection against highly virulent infectious bursal disease virus. J Vet Sci 7:3 (2006), 241–247.
28. Fahey, K.J., Chapman, A.J., Macreadie, I.G., Vaughan, P.R., McKern, N.M., Skicko, J.I., et al. A recombinant subunit vaccine that protects progeny chickens from infectious bursal disease. Avian Pathol 20:3 (1991), 447–460.
29. Wu, H., Singh, N.K., Locy, R.D., Scissum-Gunn, K., Giambrone, J.J., Immunization of chickens with VP2 protein of infectious bursal disease virus expressed in Arabidopsis thaliana. Avian Dis 48:3 (2004), 663–668.
30. Kweon, M.N., Recent progress in mucosal immunology and vaccine development. Exp Mol Med, 2014, 46e86.
31. Abdul, M.N.E., Mat, I.N., Alitheen, N.B., Song, A.A., Rahim, R.A., IRES-incorporated lactococcal bicistronic vector for target gene expression in a eukaryotic system. Plasmid, 2014, 7326–7333.
32. Kim, S.H., Seo, K.W., Kim, J., Lee, K.Y., Jang, Y.S., The M cell-targeting ligand promotes antigen delivery and induces antigen-specific immune responses in mucosal vaccination. J Immunol 185:10 (2010), 5787–5795.
33. Pasetti, M.F., Simon, J.K., Sztein, M.B., Levine, M.M., Immunology of gut mucosal vaccines. Immunol Rev 239:1 (2011), 125–148.
34. Yanagibashi, T., Hosono, A., Oyama, A., Tsuda, M., Hachimura, S., Takahashi, Y., et al. Bacteroides induce higher IgA production than Lactobacillus by increasing activation-induced cytidine deaminase expression in B cells in murine Peyer's patches. Biosci Biotechnol Biochem 73:2 (2009), 372–377.